Literature DB >> 26949657

Central serous chorioretinopathy: from glucocorticoids to light intensity.

Amir Norouzpour1, Majid Abrishami2.   

Abstract

Central serous chorioretinopathy (CSC) is characterized by a localized accumulation of subretinal fluid and an idiopathic focal leakage from choroidal vessels. The exact pathogenesis of CSC, however, still remains obscure. In this paper, we hypothesized that CSC may result from a response of choroidal vessels to an acute increase in the environmental light intensity leading to a focal leakage from the choroidal vessels. High levels of glucocorticoids, in our proposed model, may cause persistence rather than initiation of the focal leakage, probably by suppressing the synthesis of collagen and extracellular matrix components and inhibiting fibroblastic activity.

Entities:  

Keywords:  central serous chorioretinopathy; choroidal vessels; glucocorticoids; light intensity; temperature

Year:  2016        PMID: 26949657      PMCID: PMC4761749          DOI: 10.18240/ijo.2016.02.25

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  23 in total

1.  Temperature modulating action of choroidal blood flow.

Authors:  L M Parver
Journal:  Eye (Lond)       Date:  1991       Impact factor: 3.775

2.  Central serous chorioretinopathy and bright light.

Authors:  Amir Norouzpour
Journal:  Acta Ophthalmol       Date:  2014-07-16       Impact factor: 3.761

3.  Choroidal blood flow. III. Reflexive control in human eyes.

Authors:  L M Parver; C R Auker; D O Carpenter
Journal:  Arch Ophthalmol       Date:  1983-10

4.  Central serous chorioretinopathy complicating solar retinopathy treated with glucocorticoids.

Authors:  E A Bouzas; P Moret; C J Pournaras
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-02       Impact factor: 3.117

5.  Central serous chorioretinopathy in African Americans.

Authors:  Uday R Desai; Amir A Alhalel; Thomas J Campen; Rhett M Schiffman; Paul A Edwards; Gordon R Jacobsen
Journal:  J Natl Med Assoc       Date:  2003-07       Impact factor: 1.798

6.  The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002.

Authors:  Anna S Kitzmann; Jose S Pulido; Nancy N Diehl; David O Hodge; James P Burke
Journal:  Ophthalmology       Date:  2008-01       Impact factor: 12.079

7.  Dexamethasone regulation of glycosaminoglycan synthesis in cultured human skin fibroblasts. Similar effects of glucocorticoid and thyroid hormones.

Authors:  T J Smith
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

8.  Central serous chorioretinopathy: a seasonal variation?

Authors:  G H Cassel; G C Brown; W H Annesley
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

9.  Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.

Authors:  Der-Chong Tsai; Shih-Jen Chen; Chin-Chou Huang; Pesus Chou; Chia-Min Chung; Po-Hsun Huang; Shing-Jong Lin; Jaw-Wen Chen; Tseng-Ji Chen; Hsin-Bang Leu; Wan-Leong Chan
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  High definition spectral domain optical coherence tomography findings in three patients with solar retinopathy and review of the literature.

Authors:  Kevin C Chen; Jesse J Jung; Alexander Aizman
Journal:  Open Ophthalmol J       Date:  2012-06-15
View more
  2 in total

1.  Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.

Authors:  Gülizar Demirok; Fatih Kocamaz; Yasemin Topalak; Yeşim Altay; Ahmet Sengun
Journal:  Int Ophthalmol       Date:  2016-06-20       Impact factor: 2.031

2.  Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a Meta-analysis.

Authors:  Zhi-Qiao Liang; Lyu-Zhen Huang; Jin-Feng Qu; Ming-Wei Zhao
Journal:  Int J Ophthalmol       Date:  2018-02-18       Impact factor: 1.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.